BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Catalyst Calendar//CN-US Event Research//ZH
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Catalyst Calendar
X-WR-CALDESC:Market-moving event research, reminders and post-event review.
BEGIN:VEVENT
UID:evt-eyepoint-duravyu-wet-amd-phase3-readout-mid2026@catalyst-calendar.local
DTSTAMP:20260720T200556Z
DTSTART:20260715T130000Z
DTEND:20260715T133000Z
SUMMARY:EyePoint DURAVYU湿性AMD三期LUGANO/LUCIA顶线数据读出窗口
DESCRIPTION:EyePoint预计DURAVYU湿性AMD三期LUGANO顶线数据于2026年中读出，LUCIA随后读出。该事件可能影响长效眼科抗VEGF替代疗法、湿性AMD治疗负担和视网膜市场竞争格局。\\nImpact score: 80\\nExpected: 市场将关注DURAVYU是否在56周非劣效终点、注射负担降低和安全性方面支持NDA路径。\\nAffected: EYPT(subject\, unknown\, score 94)\; REGN(peer\, mixed\, score 58)\; RHHBY(peer\, mixed\, score 52)\; XBI(etf\, mixed\, score 50)\\nSources: EyePoint DSMC update: https://investors.eyepoint.bio/news-releases/news-release-details/eyepoint-announces-third-consecutive-positive-dsmc\\nEyePoint Q1 2026 update: https://investors.eyepoint.bio/news-releases/news-release-details/eyepoint-reports-first-quarter-2026-financial-results-and\\nEyePoint programs page: https://eyepoint.bio/our-programs/\\nInformation only. Not investment advice.
URL:https://0.0.0.0:3000/?event=evt-eyepoint-duravyu-wet-amd-phase3-readout-mid2026
CATEGORIES:guidance\,US\,clinical readout\,Phase 3\,wet AMD\,ophthalmology
SEQUENCE:0
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:Review catalyst preview: EyePoint DURAVYU湿性AMD三期LUGANO/LUCIA顶线数据读出窗口
END:VALARM
BEGIN:VALARM
TRIGGER:PT24H
ACTION:DISPLAY
DESCRIPTION:Complete post-event review: EyePoint DURAVYU湿性AMD三期LUGANO/LUCIA顶线数据读出窗口
END:VALARM
END:VEVENT
END:VCALENDAR